Related Experiment Video
Updated: Jul 2, 2026
09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Warfarin-associated intracerebral hemorrhage
Anna Cavallini1, Simona Fanucchi, Alessandra Persico
1UC Malattie Cerebrovascolari/Stroke Unit IRCCS Fondazione Istituto Neurologico C. Mondino, Via Mondino 2, 27100, Pavia, Italy. anna.cavallini@mondino.it
Summary
Intracerebral hemorrhage (ICH), a severe complication of oral anticoagulant therapy (OAT), has high mortality. Risk factors include age, blood pressure, and anticoagulation intensity, necessitating further clinical trials for effective treatment.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Intracerebral hemorrhage (ICH) is a critical complication of oral anticoagulant therapy (OAT).
- ICH carries a mortality rate exceeding 50%.
- Key risk factors include advanced patient age, high systolic blood pressure, anticoagulation intensity, and prior cerebral ischemia.
Purpose of the Study:
- To review the current landscape of intracerebral hemorrhage in patients undergoing oral anticoagulant therapy.
- To highlight the limitations of existing acute treatments and the need for evidence-based clinical outcome trials.
Main Methods:
- Review of existing literature on intracerebral hemorrhage associated with oral anticoagulant therapy.
- Analysis of identified risk factors and current treatment modalities.
Main Results:
- Established risk factors for ICH in OAT patients include age, hypertension, anticoagulation intensity, and history of stroke.
- Available acute treatments for ICH have significant side effects.
- No randomized clinical trials have assessed the clinical outcomes of current ICH treatments.
Conclusions:
- Intracerebral hemorrhage is a major, life-threatening complication of OAT.
- Further research, including randomized clinical trials, is essential to optimize treatment strategies.
- Future trials should focus on agent choice, dosage, administration timing, and managing side effects.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.